Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Mantecorp Industria Quimica e Farmaceutica Ltd.

ClinicalTrials.gov lists Mantecorp Industria Quimica e Farmaceutica Ltd. as lead sponsor of 10 trials. It has 4 approved assets.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

2 0 2002 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Mantecorp Industria Quimica e Farmaceutica Ltd.: 10 lead-sponsored trials and 0 legal-entity registrations.

Get the Mantecorp Industria Quimica e Farmaceutica Ltd. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (17)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Bites and Stings 2
Burns 2
Insect Bites and Stings 2
Photosensitivity Disorders 2
Sunburn 2

Trials by start year as sponsor or collaborator (4)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2011 1
2010 2
2007 1
2002 1

Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (4)

Shown in this order: max phase first.

Approved assets
Drug Trials
ibuprofen, dipyrone, acetaminophen 1
Asmanex twisthaler 1
Dexchlorpheniramine 1
IBUPROFEN 1

Journals published in (1)

Journals published in
Journal Publications
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 1

Latest dated events (5)

Shown in this order: newest first.

Latest dated events
Date Event Source
2011-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2010-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2010-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2007-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2002-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (6)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
APOH Trial sponsor Named in trial inclusion criteria
PSMB7 Trial sponsor Named in trial inclusion criteria
PSMA6 Trial sponsor Named in trial exclusion criteria
APOH Trial sponsor Mentioned in trial text
PSMA6 Trial sponsor Mentioned in trial text

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.